Safety, tolerability, PK/PD and preliminary efficacy of NKTR-255, a novel IL-15 receptor agonist, in patients with relapsed/refractory hematologic malignancies Meeting Abstract
| Authors: | Patel, K.; Shah, N.; Tan, A.; Cowan, A. J.; Turtle, C. J.; Hofmeister, C. C.; Choi, T.; Saeed, H.; Chavez, J. C.; Pianko, M. J.; Gandhi, M.; Chaudhry, S. A.; Lee, Z.; Dixit, N.; Fanton, C.; Wang, X.; Xu, H.; Marcondes, M. Q.; Tagliaferri, M. A.; Zalevsky, J.; Perales, M. A. |
| Abstract Title: | Safety, tolerability, PK/PD and preliminary efficacy of NKTR-255, a novel IL-15 receptor agonist, in patients with relapsed/refractory hematologic malignancies |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 10357 |
| End Page: | 10359 |
| Language: | English |
| ACCESSION: | WOS:000893230303164 |
| DOI: | 10.1182/blood-2022-162539 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
